The integration of artificial intelligence into the realm of biological research represents a seismic shift in scientific processes and methodologies. This evolution is vividly illustrated by the experiences of Malek Elsayyid, a graduate student from the University of Delaware, whose academic
Accurate dietary assessment has long been a challenge in nutritional science, hampered by reliance on self-reported data from methods like questionnaires and food diaries. These are often plagued by inaccuracies due to memory lapses or intentional misreporting, and they frequently lack detailed
In the rapidly evolving field of medical research, a new compound known as DT-109 has emerged as a beacon of hope for patients suffering from heart and liver diseases. Developed at the University of Michigan, this glycine-based compound was initially created to tackle metabolic
The relentless progression of Alzheimer's disease, a debilitating neurodegenerative condition, has been closely linked to the misbehavior of two primary proteins: amyloid-beta and tau. Over the years, scientific efforts have primarily focused on addressing amyloid-beta, leading to some success but
Despite increasing investments and rising costs, the pharmaceutical industry's internal rate of return (IRR) from research and development (R&D) has been on a downward trajectory for decades. Recently, however, an analysis indicates the possibility of a resurgence in R&D returns, a development that
Introducing Ivan Kairatov, a distinguished authority in biopharmaceutical innovation and technological advancements. With extensive experience in research and development, Ivan provides a unique perspective on the acquisition of Althea by PCI Pharma. This interview delves into how such strategic
